M4MM
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the ...
Virginia Cannabis Licenses Delayed Again After Spanberger Veto
RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the ...
Cannabis 3.0: Why the Next Phase of the Industry Will Be Built on Platforms, Not Products
NEW YORK- The Cannabis industry is entering a new phase of development. The first phase of the legal Cannabis market was defined by access. Cannabis 1.0 was about legalization, licensing, compliance, and the basic right ...
What’s in a Jar? For Cannabis Concentrate Brands, Quite a Lot
LOS ANGELES – The packaging debate in Cannabis manufacturing rarely makes headlines. But the choice between glass and plastic for concentrate products is one that shapes what a brand becomes and what it can prove. ...
UK Medical Cannabis H1 2025: The Market Still Running on Trust
LONDON – You won't find the echoes of this revolution in the National Health Service (NHS) waiting lists or General Practitioner (GP) surgeries. It lives instead in a constellation of private clinics spread across the ...
Virginia Cannabis Licenses Delayed Again After Spanberger Veto
RICHMOND-Virginia’s long-delayed adult-use Cannabis market has suffered another major setback after Governor Abigail Spanberger vetoed legislation that would have created a regulated retail sales framework for the Commonwealth. The veto means Virginia will remain in ...
Planet 13 Secures Florida Approval for BHO Extraction Lab
LAS VEGAS – Planet 13 Holdings Inc. announced that it has received approval from the Florida Office of Medical Marijuana Use (OMMU) for its butane hash oil (BHO) extraction facility in the state. The approval ...
FDA Grants Breakthrough Designation to Vertanical Cannabis-Based Pain Drug
BERLIN – The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to VER-01, a Cannabis-derived, non-opioid investigational drug developed by Germany's VERTANICAL for the treatment of chronic low back pain. VER-01 is ...
Apollo Acquires Emerald in $1.5B Deal: What’s Next for MJBizCon?
LOS ANGELES – Apollo Global Management Inc., one of the world's most powerful alternative asset firms, announced that its managed funds have entered into definitive agreements to acquire Emerald Holding, Inc., the owner of MJBizCon ...
Ascend Wellness Shuts Down Lansing Cultivation Facility
LANSING – In a move that reflects ongoing adjustments in Michigan’s Cannabis sector, Ascend Wellness Holdings is shutting down operations at its Lansing cultivation site. The decision comes after a fire late last year and ...
Cannabis and Alcohol Push Back Against Proposed Hemp Regulation Bill
WASHINGTON – Competing industry interests are shaping the debate over federal hemp policy as lawmakers weigh alternatives to an impending ban on many hemp-derived products. A new legislative effort highlights the tensions between established markets ...
Research and Markets Report Sets a $28B Target on Cannabis Tech
DUBLIN – The Cannabis industry has transformed from plant cultivation to infrastructure development. Today, institutional-grade technologies reshape the way the global supply chain works, and the numbers behind this evolution are capturing the attention of ...
Europe Medical Cannabis to Reach $13 Billion by 2034, IMARC Group Reports
NEW YORK – A fresh industry report highlights substantial potential in Europe's regulated medical Cannabis market as more countries refine access rules and patient numbers climb. The analysis from IMARC Group points to steady expansion ...
Bioxyne Double-Strikes in LATAM and Europe
SYDNEY – Bioxyne Limited, an international health and life sciences company focused on the manufacturing and distribution of novel medicines, including medical Cannabis, psilocybin, and MDMA, has signed two new commercial agreements – one stretching ...
Rubicon Organics Reports Q1 2026 Financial Results
VANCOUVER – Rubicon Organics Inc. delivered its first-quarter report, revealing results that show both progress and short-term pressures common in an industry shifting toward larger-scale operations – all while balancing strong market share gains with ...
BREAKING: Colorado Passes Landmark Ibogaine Research Bill, Expanding the State’s Natural Medicine Framework
DENVER- Colorado has taken another major step in the evolution of regulated psychedelic medicine. The Colorado legislature has passed House Bill 26-1325, a landmark measure that establishes an ibogaine research pilot program within the state’s ...
The DEA Window: The Real Fight Is Over Who Qualifies as Medical Cannabis
WASHINGTON, D.C. - The real significance of the DEA window is not that the Cannabis industry needs another explanation of legalization. Operators, investors, attorneys, and regulators already understand the limits of federal reform. The more ...
